Literature DB >> 10872503

In planta expression of HIV-1 p24 protein using an RNA plant virus-based expression vector.

G Zhang1, C Leung, L Murdin, B Rovinski, K A White.   

Abstract

Plant viruses show significant potential as expression vectors for the production of foreign proteins (e.g., antigens) in plants. The HIV-1 p24 nucleocapsid protein is an important early marker of HIV infection and has been used as an antigen in the development of HIV vaccines. Toward developing a plant-based expression system for the production of p24, we have investigated the use of a (positive)-strand RNA plant virus, tomato bushy stunt virus (TBSV), as an expression vector. The HIV p24 open reading frame (ORF) was introduced into a cloned cDNA copy of the TBSV genome as an in-frame fusion with a 5'-terminal portion of the TBSV coat protein ORF. In vitro-generated RNA transcripts corresponding to the engineered virus vector were infectious when inoculated into plant protoplasts; Northern and Western blot analyses verified the accumulation of a predicted p24-encoding viral subgenomic mRNA and the production of p24 fusion product. Whole-plant infections with the viral vector led to the accumulation of p24 fusion protein in inoculated leaves, which cross-reacted with p24-specific antibodies, thus confirming the maintenance of key antigenic determinants. This study is the first to demonstrate that TBSV can be engineered to express a complete foreign protein of clinical importance. Strategies for optimizing protein yield from this viral vector are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10872503     DOI: 10.1385/mb:14:2:99

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  20 in total

1.  p24 antigen and HIV screening.

Authors:  J J Lefrère; A M Courouce; P Rouger; N Duedari; M H Elghouzzi
Journal:  Lancet       Date:  1992-04-18       Impact factor: 79.321

2.  Plant virus gene vectors for transient expression of foreign proteins in plants.

Authors:  H B Scholthof; K B Scholthof; A O Jackson
Journal:  Annu Rev Phytopathol       Date:  1996       Impact factor: 13.078

3.  p24 antigenaemia as a predictor of good immunological responsiveness to zidovudine therapy in asymptomatic HIV infection.

Authors:  M Montroni; G Silvestri; L Butini; C Bartocci; C Regnery; G Danieli
Journal:  AIDS       Date:  1992-03       Impact factor: 4.177

Review 4.  Use of viral replicons for the expression of genes in plants.

Authors:  C Porta; G P Lomonossoff
Journal:  Mol Biotechnol       Date:  1996-06       Impact factor: 2.695

5.  Plants are not just passive creatures!

Authors:  T Arakawa; W H Langridge
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

6.  Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.

Authors:  S J Martin; A Vyakarnam; R Cheingsong-Popov; D Callow; K L Jones; J M Senior; S E Adams; A J Kingsman; P Matear; F M Gotch
Journal:  AIDS       Date:  1993-10       Impact factor: 4.177

7.  RNA determinants of junction site selection in RNA virus recombinants and defective interfering RNAs.

Authors:  K A White; T J Morris
Journal:  RNA       Date:  1995-12       Impact factor: 4.942

8.  Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1.

Authors:  V Yusibov; A Modelska; K Steplewski; M Agadjanyan; D Weiner; D C Hooper; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

9.  The complete genome structure and synthesis of infectious RNA from clones of tomato bushy stunt virus.

Authors:  P Q Hearne; D A Knorr; B I Hillman; T J Morris
Journal:  Virology       Date:  1990-07       Impact factor: 3.616

10.  The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker.

Authors:  S A Spector; C Kennedy; J A McCutchan; S A Bozzette; R G Straube; J D Connor; D D Richman
Journal:  J Infect Dis       Date:  1989-05       Impact factor: 5.226

View more
  10 in total

Review 1.  Current status and perspectives of plant-based candidate vaccines against the human immunodeficiency virus (HIV).

Authors:  Sergio Rosales-Mendoza; Néstor Rubio-Infante; Dania O Govea-Alonso; Leticia Moreno-Fierros
Journal:  Plant Cell Rep       Date:  2011-12-13       Impact factor: 4.570

2.  High-level expression of the HIV-1 Pr55gag polyprotein in transgenic tobacco chloroplasts.

Authors:  Nunzia Scotti; Fiammetta Alagna; Enrico Ferraiolo; Gelsomina Formisano; Lorenza Sannino; Luigi Buonaguro; Angelo De Stradis; Alessandro Vitale; Luigi Monti; Stefania Grillo; Franco M Buonaguro; Teodoro Cardi
Journal:  Planta       Date:  2009-02-21       Impact factor: 4.540

3.  High level soluble expression, one-step purification and characterization of HIV-1 p24 protein.

Authors:  Baozhong Zhang; Dabin Liu; Zuoyi Bao; Bin Chen; Cun Li; Huanhuan Jiang; Xiaona Wang; Zhiqiang Mi; Xiaoping An; Jun Lu; Yigang Tong
Journal:  Virol J       Date:  2011-06-22       Impact factor: 4.099

4.  Expression of Human Immunodeficiency Virus type 1 (HIV-1) coat protein genes in plants using cotton leaf curl Multan betasatellite-based vector.

Authors:  Elham Ataie Kachoie; Seyed Ali Akbar Behjatnia; Sara Kharazmi
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

5.  Production of HIV-1 p24 protein in transgenic tobacco plants.

Authors:  G Gary Zhang; Lauren Rodrigues; Benjamin Rovinski; K Andrew White
Journal:  Mol Biotechnol       Date:  2002-02       Impact factor: 2.695

Review 6.  Viral vectors for production of recombinant proteins in plants.

Authors:  Chiara Lico; Qiang Chen; Luca Santi
Journal:  J Cell Physiol       Date:  2008-08       Impact factor: 6.384

Review 7.  Use of viral vectors for vaccine production in plants.

Authors:  M Carmen Cañizares; Liz Nicholson; George P Lomonossoff
Journal:  Immunol Cell Biol       Date:  2005-06       Impact factor: 5.126

Review 8.  Plant-based strategies aimed at expressing HIV antigens and neutralizing antibodies at high levels. Nef as a case study.

Authors:  Carla Marusic; Alessandro Vitale; Emanuela Pedrazzini; Marcello Donini; Lorenzo Frigerio; Ralph Bock; Philip J Dix; Matthew S McCabe; Michele Bellucci; Eugenio Benvenuto
Journal:  Transgenic Res       Date:  2009-01-25       Impact factor: 2.788

9.  Expression of HIV-1 antigens in plants as potential subunit vaccines.

Authors:  Ann Meyers; Ereck Chakauya; Enid Shephard; Fiona L Tanzer; James Maclean; Alisson Lynch; Anna-Lise Williamson; Edward P Rybicki
Journal:  BMC Biotechnol       Date:  2008-06-23       Impact factor: 2.563

Review 10.  Plants as bioreactors for the production of vaccine antigens.

Authors:  Siddharth Tiwari; Praveen C Verma; Pradhyumna K Singh; Rakesh Tuli
Journal:  Biotechnol Adv       Date:  2009-04-06       Impact factor: 14.227

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.